| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Angelika C Gruessner | |
| P2860 | cites work | Alemtuzumab induction and steroid-free maintenance immunosuppression in pancreas transplantation | Q33381369 |
| Minimization and withdrawal of steroids in pancreas and islet transplantation | Q37294525 | ||
| Are there still roles for exocrine bladder drainage and portal venous drainage for pancreatic allografts? | Q37428600 | ||
| Pancreas transplantation in the United States: a review | Q37654089 | ||
| The pancreas allograft donor: current status, controversies, and challenges for the future | Q37729275 | ||
| Is there a role for pancreas transplantation in type 2 diabetes mellitus? | Q37766418 | ||
| Compative study of bladder versus enteric drainage in pancreas transplantation | Q45810021 | ||
| Outcome of pancreas transplantation in recipients older than 50 years: a single-centre experience | Q82941922 | ||
| Pancreas transplantation | Q83893794 | ||
| P433 | issue | 1 | |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 6-16 | |
| P577 | publication date | 2011-05-10 | |
| P1433 | published in | The review of diabetic studies : RDS | Q26853988 |
| P1476 | title | 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR) | |
| P478 | volume | 8 |
| Q35834999 | 125 Cases of duodenoduodenostomy in pancreas transplantation: a single-centre experience of an alternative enteric drainage |
| Q64956944 | 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation. |
| Q36964944 | A composite risk model for predicting technical failure in pancreas transplantation |
| Q52147743 | A registry analysis of damage to the deceased donor pancreas during procurement. |
| Q50941769 | A single-centre experience of Roux-en-Y enteric drainage for pancreas transplantation. |
| Q50947613 | Advances in pancreas transplantation. |
| Q40270917 | Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients. |
| Q92910500 | Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes |
| Q39199584 | Arteriojejunal Fistula Presenting with Recurrent Obscure GI Hemorrhage in a Patient with a Failed Pancreas Allograft |
| Q38114613 | Beyond islet transplantation in diabetes cell therapy: from embryonic stem cells to transdifferentiation of adult cells |
| Q86047183 | Case report: pancreas graft with a duodenal complication rescued using total duodenectomy |
| Q38530484 | Clinical implementation of islet transplantation: A current assessment |
| Q39005220 | Clinical pancreatic islet transplantation. |
| Q38696583 | Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection - a retrospective study. |
| Q43479968 | Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients |
| Q27329406 | Crucial role for neuronal nitric oxide synthase in early microcirculatory derangement and recipient survival following murine pancreas transplantation |
| Q48455709 | Curing diabetes with transplantation? |
| Q41105688 | Delayed graft duodenal perforation due to impacted food five years after simultaneous pancreas-kidney transplantation: A case report. |
| Q39513531 | Diabetes treatment in 2025: can scientific advances keep pace with prevalence? |
| Q33583012 | Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease |
| Q37346590 | Donor Characteristics of Pancreas Transplantation in Australia and New Zealand: A Cohort Study 1984-2014 |
| Q89049431 | Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation |
| Q41486538 | Duodenal leaks after pancreas transplantation with enteric drainage - characteristics and risk factors. |
| Q35073484 | Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation |
| Q39386173 | Encapsulated Islet Transplantation: Where Do We Stand? |
| Q92050455 | Endovascular Treatment of Pseudoaneurysm After Simultaneous Pancreas-Kidney Transplant: A Case Report |
| Q48599738 | Evaluation of insulin independence using 11C-methionine positron emission tomography after living-donor and brain-dead donor pancreas transplantation |
| Q51330313 | Examination of carbohydrate metabolism parameters after simultaneous pancreas-kidney transplantation. |
| Q53085494 | Excellent outcomes can be achieved in young pancreas transplant alone recipients by addition of sirolimus to maintenance immunosuppression regimen. |
| Q38562572 | Extracorporeal machine perfusion of the pancreas: technical aspects and its clinical implications--a systematic review of experimental models |
| Q57043638 | Fence Angioplasty Prevents Narrowing of Venous Anastomosis in Solitary Pancreas Transplant |
| Q48053510 | Health-related quality of life may improve after transplantation in pancreas-kidney recipients. |
| Q87599592 | High urine amylase level and the risk of enteric conversion in solitary pancreas transplant recipients |
| Q43043555 | Imaging in pancreatic transplants. |
| Q38136504 | Imaging pancreas transplants |
| Q38162892 | Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective |
| Q86524799 | Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease |
| Q87634342 | In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone |
| Q38106742 | Induction therapy in pancreas transplantation |
| Q37086379 | Influence of donor-recipient sex mismatch on long-term survival of pancreatic grafts |
| Q45418418 | Intercellular adhesion molecular-1, Fas, and Fas ligand as diagnostic biomarkers for acute allograft rejection of pancreaticoduodenal transplantation in pigs |
| Q94338127 | Interventions for improving medication adherence in solid organ transplant recipients |
| Q34972386 | Islet and stem cell encapsulation for clinical transplantation |
| Q38689971 | Islet cell transplant: Update on current clinical trials |
| Q37088225 | Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome |
| Q38240555 | Islet xenotransplantation: what is the optimal age of the islet-source pig? |
| Q38256872 | Late pancreas retransplantation. |
| Q43771162 | Living donor kidney transplantation preceding pancreas transplantation reduces mortality in type 1 diabetics with end-stage renal disease. |
| Q40162549 | Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation |
| Q92474650 | Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: An observational cohort study |
| Q39043916 | Management of Graft Duodenal Leak in Simultaneous Pancreas Kidney Transplant-a Case Report from India and Review of Literature |
| Q49497791 | Mouse Model for Pancreas Transplantation Using a Modified Cuff Technique |
| Q46328734 | Multi detector computed tomography (MDCT) for the diagnosis of early complications after pancreas transplantation |
| Q43465704 | Multivariate analysis of complications after simultaneous pancreas and kidney transplantation. |
| Q39387959 | Optimizing outcomes in pancreas transplantation: Impact of organ preservation time |
| Q48146306 | Outcomes in Pancreas Transplantation With Exocrine Drainage Through a Duodenoduodenostomy Versus Duodenojejunostomy |
| Q37346582 | Outcomes of Pancreatic Islet Allotransplantation Using the Edmonton Protocol at the University of Chicago |
| Q89029615 | Pancreas Transplantation at a Single Latin-American Center; Overall Results with Type 1 and Type 2 Diabetes Mellitus |
| Q57457162 | Pancreas Transplantation of Non-Traditional Recipients |
| Q45170563 | Pancreas graft survival in simultaneous pancreas-kidney versus pancreas-after-kidney and pancreas alone transplantations: a single institution experience |
| Q58718928 | Pancreas grafts for transplantation from donors with hypertension: an analysis of the scientific registry of transplant recipients database |
| Q34761327 | Pancreas transplantation in type II diabetes mellitus |
| Q39197755 | Pancreas transplantation with enteroanastomosis to native duodenum poses technical challenges--but offers improved endoscopic access for scheduled biopsies and therapeutic interventions |
| Q38177374 | Pancreas transplantation with portal venous drainage with an emphasis on technical aspects |
| Q34699278 | Pancreas transplantation: The Wake Forest experience in the new millennium |
| Q37502735 | Pancreas transplantation: a single-institution experience in Japan |
| Q28084546 | Pancreas transplantation: review |
| Q41409008 | Pancreas-Kidney transplantation: Impact of dialysis modality on the outcome. |
| Q38655967 | Pancreatic Allograft Thrombosis: Suggestion for a CT grading system and management algorithm |
| Q51325262 | Pancreatic autoantibodies after pancreas-kidney transplantation - do they matter? |
| Q38921858 | Porcine Islet Xenografts: a Clinical Source of ß-Cell Grafts |
| Q38957287 | Portal Vein Thrombosis After Splenic and Pancreatic Surgery |
| Q51172334 | Portal venous versus systemic venous drainage of pancreas grafts: impact on long-term results. |
| Q90320222 | Pre-hepatic and pre-pancreatic transplant donor evaluation |
| Q40959943 | Preserving the Pancreas Graft: Outcomes of Surgical Repair of Duodenal Leaks in Enterically Drained Pancreas Allografts |
| Q26865305 | Progress in abdominal organ transplantation |
| Q35758489 | Results of pancreas transplantation alone with special attention to native kidney function and proteinuria in type 1 diabetes patients |
| Q51054688 | Risk factors of pancreatic graft loss and death of receptor after simultaneous pancreas/kidney transplantation. |
| Q38159475 | Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention. |
| Q90216900 | Sex matching does not impact the outcome after simultaneous pancreas-kidney transplantation |
| Q43529296 | Similar results with solitary pancreas transplantation compared with simultaneous pancreas-kidney transplantation in the new millennium |
| Q39288556 | Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry |
| Q38309889 | Simultaneous pancreas and kidney transplantation: current trends and future directions |
| Q38923333 | Simultaneous pancreas-kidney transplant for type I diabetes with renal failure: Anaesthetic considerations |
| Q42201555 | Simultaneous pancreas-kidney transplantation with duodeno-duodenal anastomosis |
| Q93379692 | Solid organ transplantation in the 21st century |
| Q60310426 | Solid pancreas transplant: Pushing forward |
| Q38602263 | Solitary pancreas transplantation: a review of the UK experience over a period of 10 yr. |
| Q42693347 | Stem Cell-Derived Beta Cells for Treatment of Type 1 Diabetes? |
| Q104802055 | Successful Expectant Management of Nonocclusive Thrombosis in Simultaneous Pancreas-Kidney Transplantation |
| Q38014104 | T cell autoreactivity in the transplant milieu. |
| Q38254279 | Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions |
| Q24200247 | Tacrolimus versus cyclosporin for simultaneous pancreas-kidney transplant recipients |
| Q35128350 | The IKEM pancreas and islet transplant program as part of healthcare for type 1 diabetes patients: retrospective analysis of outcome from 1983 to 2010. |
| Q47378334 | The Pancreas Can Take the Cold: Lower Waitlist Times Through Importation |
| Q58776430 | The effects of donor age on organ transplants: A review and implications for aging research |
| Q38043510 | The metabolic and toxicological considerations for immunosuppressive drugs used during pancreas transplantation |
| Q47682167 | The rise and potential fall of pancreas transplantation |
| Q43751401 | The use of venous jump grafts in pancreatic transplantation - no difference in patient or allograft outcomes - an update of the UNOS database |
| Q28083650 | Toward beta cell replacement for diabetes |
| Q64067866 | Transgenic substitution with Greater Amberjack Seriola dumerili fish insulin 2 in NOD mice reduces beta cell immunogenicity |
| Q30490719 | Transplant Center Volume and the Risk of Pancreas Allograft Failure |
| Q38230451 | Transplant options for patients with type 2 diabetes and chronic kidney disease |
| Q36555232 | Treatment with tetrahydrobiopterin overcomes brain death-associated injury in a murine model of pancreas transplantation. |
| Q28242092 | Type 1 diabetes through the life span: a position statement of the American Diabetes Association |
| Q38246132 | Type 2 diabetes: is pancreas transplantation an option? |
| Q52982735 | Usefulness of Modified Dindo-Clavien Scale to Evaluate the Correlation Between the Severity of Surgical Complications and Complications Related to the Renal and Pancreatic Grafts After Simultaneous Kidney and Pancreas Transplantation. |
| Q88637581 | Using Mesenchymal Stromal Cells in Islet Transplantation |
| Q38385791 | Value of magnetic resonance imaging in evaluating the pancreatic allograft transplant complications |
| Q38093549 | What would surgeons like from materials scientists? |
| Q36870263 | Why is organ transplantation clinically important? |
Search more.